Global RNA-LNP (Lipid Nanoparticle) Formulation Market Insights, Forecast to 2030

TABLE OF CONTENTS

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global RNA-LNP (Lipid Nanoparticle) Formulation Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
  • 1.2.2 Circular RNA-LNP Formulation
  • 1.2.3 mRNA-LNP Formulation
  • 1.2.4 Other
• 1.3 Market by Application
  • 1.3.1 Global RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Application: 2019 VS 2023 VS 2030
  • 1.3.2 Drug Delivery
  • 1.3.3 Vaccine Development
  • 1.3.4 Other
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global RNA-LNP (Lipid Nanoparticle) Formulation Market Perspective (2019-2030)
• 2.2 Global RNA-LNP (Lipid Nanoparticle) Formulation Growth Trends by Region
  • 2.2.1 Global RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Region: 2019 VS 2023 VS 2030
  • 2.2.2 RNA-LNP (Lipid Nanoparticle) Formulation Historic Market Size by Region (2019-2024)
  • 2.2.3 RNA-LNP (Lipid Nanoparticle) Formulation Forecasted Market Size by Region (2025-2030)
• 2.3 RNA-LNP (Lipid Nanoparticle) Formulation Market Dynamics
  • 2.3.1 RNA-LNP (Lipid Nanoparticle) Formulation Industry Trends
  • 2.3.2 RNA-LNP (Lipid Nanoparticle) Formulation Market Drivers
  • 2.3.3 RNA-LNP (Lipid Nanoparticle) Formulation Market Challenges
  • 2.3.4 RNA-LNP (Lipid Nanoparticle) Formulation Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Revenue RNA-LNP (Lipid Nanoparticle) Formulation by Players
  • 3.1.1 Global RNA-LNP (Lipid Nanoparticle) Formulation Revenue by Players (2019-2024)
  • 3.1.2 Global RNA-LNP (Lipid Nanoparticle) Formulation Revenue Market Share by Players (2019-2024)
• 3.2 Global RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Global Key Players of RNA-LNP (Lipid Nanoparticle) Formulation, Ranking by Revenue, 2022 VS 2023 VS 2024
• 3.4 Global RNA-LNP (Lipid Nanoparticle) Formulation Market Concentration Ratio
  • 3.4.1 Global RNA-LNP (Lipid Nanoparticle) Formulation Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by RNA-LNP (Lipid Nanoparticle) Formulation Revenue in 2023
• 3.5 Global Key Players of RNA-LNP (Lipid Nanoparticle) Formulation Head office and Area Served
• 3.6 Global Key Players of RNA-LNP (Lipid Nanoparticle) Formulation, Product and Application
• 3.7 Global Key Players of RNA-LNP (Lipid Nanoparticle) Formulation, Date of Enter into This Industry
• 3.8 Mergers & Acquisitions, Expansion Plans

4 RNA-LNP (Lipid Nanoparticle) Formulation Breakdown Data by Type

• 4.1 Global RNA-LNP (Lipid Nanoparticle) Formulation Historic Market Size by Type (2019-2024)
• 4.2 Global RNA-LNP (Lipid Nanoparticle) Formulation Forecasted Market Size by Type (2025-2030)

5 RNA-LNP (Lipid Nanoparticle) Formulation Breakdown Data by Application

• 5.1 Global RNA-LNP (Lipid Nanoparticle) Formulation Historic Market Size by Application (2019-2024)
• 5.2 Global RNA-LNP (Lipid Nanoparticle) Formulation Forecasted Market Size by Application (2025-2030)

6 North America

• 6.1 North America RNA-LNP (Lipid Nanoparticle) Formulation Market Size (2019-2030)
• 6.2 North America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Type
  • 6.2.1 North America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Type (2019-2024)
  • 6.2.2 North America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Type (2025-2030)
  • 6.2.3 North America RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Type (2019-2030)
• 6.3 North America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Application
  • 6.3.1 North America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Application (2019-2024)
  • 6.3.2 North America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Application (2025-2030)
  • 6.3.3 North America RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Application (2019-2030)
• 6.4 North America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Country
  • 6.4.1 North America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Country: 2019 VS 2023 VS 2030
  • 6.4.2 North America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Country (2019-2024)
  • 6.4.3 North America RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Country (2025-2030)
  • 6.4.4 United States
  • 6.4.5 Canada

7 Europe

• 7.1 Europe RNA-LNP (Lipid Nanoparticle) Formulation Market Size (2019-2030)
• 7.2 Europe RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Type
  • 7.2.1 Europe RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Type (2019-2024)
  • 7.2.2 Europe RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Type (2025-2030)
  • 7.2.3 Europe RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Type (2019-2030)
• 7.3 Europe RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Application
  • 7.3.1 Europe RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Application (2019-2024)
  • 7.3.2 Europe RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Application (2025-2030)
  • 7.3.3 Europe RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Application (2019-2030)
• 7.4 Europe RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Country
  • 7.4.1 Europe RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Country: 2019 VS 2023 VS 2030
  • 7.4.2 Europe RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Country (2019-2024)
  • 7.4.3 Europe RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Country (2025-2030)
  • 7.4.4 Germany
  • 7.4.5 France
  • 7.4.6 U.K.
  • 7.4.7 Italy
  • 7.4.8 Russia
  • 7.4.9 Nordic Countries

8 China

• 8.1 China RNA-LNP (Lipid Nanoparticle) Formulation Market Size (2019-2030)
• 8.2 China RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Type
  • 8.2.1 China RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Type (2019-2024)
  • 8.2.2 China RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Type (2025-2030)
  • 8.2.3 China RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Type (2019-2030)
• 8.3 China RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Application
  • 8.3.1 China RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Application (2019-2024)
  • 8.3.2 China RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Application (2025-2030)
  • 8.3.3 China RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia RNA-LNP (Lipid Nanoparticle) Formulation Market Size (2019-2030)
• 9.2 Asia RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Type
  • 9.2.1 Asia RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Type (2019-2024)
  • 9.2.2 Asia RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Type (2025-2030)
  • 9.2.3 Asia RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Type (2019-2030)
• 9.3 Asia RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Application
  • 9.3.1 Asia RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Application (2019-2024)
  • 9.3.2 Asia RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Application (2025-2030)
  • 9.3.3 Asia RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Application (2019-2030)
• 9.4 Asia RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Region
  • 9.4.1 Asia RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Region: 2019 VS 2023 VS 2030
  • 9.4.2 Asia RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Region (2019-2024)
  • 9.4.3 Asia RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Region (2025-2030)
  • 9.4.4 Japan
  • 9.4.5 South Korea
  • 9.4.6 China Taiwan
  • 9.4.7 Southeast Asia
  • 9.4.8 India
  • 9.4.9 Australia

10 Middle East, Africa, and Latin America

• 10.1 Middle East, Africa, and Latin America RNA-LNP (Lipid Nanoparticle) Formulation Market Size (2019-2030)
• 10.2 Middle East, Africa, and Latin America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Type
  • 10.2.1 Middle East, Africa, and Latin America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Type (2019-2024)
  • 10.2.2 Middle East, Africa, and Latin America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Type (2025-2030)
  • 10.2.3 Middle East, Africa, and Latin America RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Type (2019-2030)
• 10.3 Middle East, Africa, and Latin America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Application
  • 10.3.1 Middle East, Africa, and Latin America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Application (2019-2024)
  • 10.3.2 Middle East, Africa, and Latin America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Application (2025-2030)
  • 10.3.3 Middle East, Africa, and Latin America RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Application (2019-2030)
• 10.4 Middle East, Africa, and Latin America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Country
  • 10.4.1 Middle East, Africa, and Latin America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Country: 2019 VS 2023 VS 2030
  • 10.4.2 Middle East, Africa, and Latin America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Country (2019-2024)
  • 10.4.3 Middle East, Africa, and Latin America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Country (2025-2030)
  • 10.4.4 Brazil
  • 10.4.5 Mexico
  • 10.4.6 Turkey
  • 10.4.7 Saudi Arabia
  • 10.4.8 Israel
  • 10.4.9 GCC Countries

11 Key Players Profiles

• 11.1 WuXi XDC
  • 11.1.1 WuXi XDC Company Details
  • 11.1.2 WuXi XDC Business Overview
  • 11.1.3 WuXi XDC RNA-LNP (Lipid Nanoparticle) Formulation Introduction
  • 11.1.4 WuXi XDC Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
  • 11.1.5 WuXi XDC Recent Development
• 11.2 GenScript
  • 11.2.1 GenScript Company Details
  • 11.2.2 GenScript Business Overview
  • 11.2.3 GenScript RNA-LNP (Lipid Nanoparticle) Formulation Introduction
  • 11.2.4 GenScript Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
  • 11.2.5 GenScript Recent Development
• 11.3 Creative Biogene
  • 11.3.1 Creative Biogene Company Details
  • 11.3.2 Creative Biogene Business Overview
  • 11.3.3 Creative Biogene RNA-LNP (Lipid Nanoparticle) Formulation Introduction
  • 11.3.4 Creative Biogene Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
  • 11.3.5 Creative Biogene Recent Development
• 11.4 Creative Biolabs
  • 11.4.1 Creative Biolabs Company Details
  • 11.4.2 Creative Biolabs Business Overview
  • 11.4.3 Creative Biolabs RNA-LNP (Lipid Nanoparticle) Formulation Introduction
  • 11.4.4 Creative Biolabs Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
  • 11.4.5 Creative Biolabs Recent Development
• 11.5 Precigenome LLC
  • 11.5.1 Precigenome LLC Company Details
  • 11.5.2 Precigenome LLC Business Overview
  • 11.5.3 Precigenome LLC RNA-LNP (Lipid Nanoparticle) Formulation Introduction
  • 11.5.4 Precigenome LLC Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
  • 11.5.5 Precigenome LLC Recent Development
• 11.6 Catalent
  • 11.6.1 Catalent Company Details
  • 11.6.2 Catalent Business Overview
  • 11.6.3 Catalent RNA-LNP (Lipid Nanoparticle) Formulation Introduction
  • 11.6.4 Catalent Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
  • 11.6.5 Catalent Recent Development
• 11.7 Curapath
  • 11.7.1 Curapath Company Details
  • 11.7.2 Curapath Business Overview
  • 11.7.3 Curapath RNA-LNP (Lipid Nanoparticle) Formulation Introduction
  • 11.7.4 Curapath Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
  • 11.7.5 Curapath Recent Development
• 11.8 Recipharm AB
  • 11.8.1 Recipharm AB Company Details
  • 11.8.2 Recipharm AB Business Overview
  • 11.8.3 Recipharm AB RNA-LNP (Lipid Nanoparticle) Formulation Introduction
  • 11.8.4 Recipharm AB Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
  • 11.8.5 Recipharm AB Recent Development
• 11.9 RiboPro
  • 11.9.1 RiboPro Company Details
  • 11.9.2 RiboPro Business Overview
  • 11.9.3 RiboPro RNA-LNP (Lipid Nanoparticle) Formulation Introduction
  • 11.9.4 RiboPro Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
  • 11.9.5 RiboPro Recent Development
• 11.10 VectorBuilder Inc.
  • 11.10.1 VectorBuilder Inc. Company Details
  • 11.10.2 VectorBuilder Inc. Business Overview
  • 11.10.3 VectorBuilder Inc. RNA-LNP (Lipid Nanoparticle) Formulation Introduction
  • 11.10.4 VectorBuilder Inc. Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
  • 11.10.5 VectorBuilder Inc. Recent Development
• 11.11 CordenPharma
  • 11.11.1 CordenPharma Company Details
  • 11.11.2 CordenPharma Business Overview
  • 11.11.3 CordenPharma RNA-LNP (Lipid Nanoparticle) Formulation Introduction
  • 11.11.4 CordenPharma Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
  • 11.11.5 CordenPharma Recent Development
• 11.12 Thermo Fisher Scientific
  • 11.12.1 Thermo Fisher Scientific Company Details
  • 11.12.2 Thermo Fisher Scientific Business Overview
  • 11.12.3 Thermo Fisher Scientific RNA-LNP (Lipid Nanoparticle) Formulation Introduction
  • 11.12.4 Thermo Fisher Scientific Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
  • 11.12.5 Thermo Fisher Scientific Recent Development
• 11.13 ProMab
  • 11.13.1 ProMab Company Details
  • 11.13.2 ProMab Business Overview
  • 11.13.3 ProMab RNA-LNP (Lipid Nanoparticle) Formulation Introduction
  • 11.13.4 ProMab Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)
  • 11.13.5 ProMab Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
    • 13.1.1.1 Research Programs/Design
    • 13.1.1.2 Market Size Estimation
    • 13.1.1.3 Market Breakdown and Data Triangulation
  • 13.1.2 Data Source
    • 13.1.2.1 Secondary Sources
    • 13.1.2.2 Primary Sources
• 13.2 Author Details
• 13.3 Disclaimer

List of Tables

Table 1. Global RNA-LNP (Lipid Nanoparticle) Formulation Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Circular RNA-LNP Formulation

Table 3. Key Players of mRNA-LNP Formulation

Table 4. Key Players of Other

Table 5. Global RNA-LNP (Lipid Nanoparticle) Formulation Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global RNA-LNP (Lipid Nanoparticle) Formulation Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Region (2019-2024)

Table 9. Global RNA-LNP (Lipid Nanoparticle) Formulation Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Region (2025-2030)

Table 11. RNA-LNP (Lipid Nanoparticle) Formulation Market Trends

Table 12. RNA-LNP (Lipid Nanoparticle) Formulation Market Drivers

Table 13. RNA-LNP (Lipid Nanoparticle) Formulation Market Challenges

Table 14. RNA-LNP (Lipid Nanoparticle) Formulation Market Restraints

Table 15. Global RNA-LNP (Lipid Nanoparticle) Formulation Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Players (2019-2024)

Table 17. Global Top RNA-LNP (Lipid Nanoparticle) Formulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA-LNP (Lipid Nanoparticle) Formulation as of 2023)

Table 18. Global RNA-LNP (Lipid Nanoparticle) Formulation Industry Ranking 2022 VS 2023

Table 19. Global 5 Largest Players Market Share by RNA-LNP (Lipid Nanoparticle) Formulation Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of RNA-LNP (Lipid Nanoparticle) Formulation, Headquarters and Area Served

Table 21. Global Key Players of RNA-LNP (Lipid Nanoparticle) Formulation, Product and Application

Table 22. Global Key Players of RNA-LNP (Lipid Nanoparticle) Formulation, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global RNA-LNP (Lipid Nanoparticle) Formulation Revenue Market Share by Type (2019-2024)

Table 26. Global RNA-LNP (Lipid Nanoparticle) Formulation Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global RNA-LNP (Lipid Nanoparticle) Formulation Revenue Market Share by Type (2025-2030)

Table 28. Global RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global RNA-LNP (Lipid Nanoparticle) Formulation Revenue Market Share by Application (2019-2024)

Table 30. Global RNA-LNP (Lipid Nanoparticle) Formulation Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global RNA-LNP (Lipid Nanoparticle) Formulation Revenue Market Share by Application (2025-2030)

Table 32. North America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Type (2019-2024) & (US$ Million)

Table 33. North America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Type (2025-2030) & (US$ Million)

Table 34. North America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Application (2019-2024) & (US$ Million)

Table 35. North America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Application (2025-2030) & (US$ Million)

Table 36. North America RNA-LNP (Lipid Nanoparticle) Formulation Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Type (2019-2024) & (US$ Million)

Table 40. Europe RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Type (2025-2030) & (US$ Million)

Table 41. Europe RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Application (2019-2024) & (US$ Million)

Table 42. Europe RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Application (2025-2030) & (US$ Million)

Table 43. Europe RNA-LNP (Lipid Nanoparticle) Formulation Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Europe RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Country (2019-2024) & (US$ Million)

Table 45. Europe RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Country (2025-2030) & (US$ Million)

Table 46. China RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Type (2019-2024) & (US$ Million)

Table 47. China RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Type (2025-2030) & (US$ Million)

Table 48. China RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Application (2019-2024) & (US$ Million)

Table 49. China RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Application (2025-2030) & (US$ Million)

Table 50. Asia RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Type (2019-2024) & (US$ Million)

Table 51. Asia RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Type (2025-2030) & (US$ Million)

Table 52. Asia RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Application (2019-2024) & (US$ Million)

Table 53. Asia RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Application (2025-2030) & (US$ Million)

Table 54. Asia RNA-LNP (Lipid Nanoparticle) Formulation Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 55. Asia RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Region (2019-2024) & (US$ Million)

Table 56. Asia RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Region (2025-2030) & (US$ Million)

Table 57. Middle East, Africa, and Latin America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Type (2019-2024) & (US$ Million)

Table 58. Middle East, Africa, and Latin America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Type (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Application (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Application (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America RNA-LNP (Lipid Nanoparticle) Formulation Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 62. Middle East, Africa, and Latin America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Country (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America RNA-LNP (Lipid Nanoparticle) Formulation Market Size by Country (2025-2030) & (US$ Million)

Table 64. WuXi XDC Company Details

Table 65. WuXi XDC Business Overview

Table 66. WuXi XDC RNA-LNP (Lipid Nanoparticle) Formulation Product

Table 67. WuXi XDC Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024) & (US$ Million)

Table 68. WuXi XDC Recent Development

Table 69. GenScript Company Details

Table 70. GenScript Business Overview

Table 71. GenScript RNA-LNP (Lipid Nanoparticle) Formulation Product

Table 72. GenScript Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024) & (US$ Million)

Table 73. GenScript Recent Development

Table 74. Creative Biogene Company Details

Table 75. Creative Biogene Business Overview

Table 76. Creative Biogene RNA-LNP (Lipid Nanoparticle) Formulation Product

Table 77. Creative Biogene Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024) & (US$ Million)

Table 78. Creative Biogene Recent Development

Table 79. Creative Biolabs Company Details

Table 80. Creative Biolabs Business Overview

Table 81. Creative Biolabs RNA-LNP (Lipid Nanoparticle) Formulation Product

Table 82. Creative Biolabs Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024) & (US$ Million)

Table 83. Creative Biolabs Recent Development

Table 84. Precigenome LLC Company Details

Table 85. Precigenome LLC Business Overview

Table 86. Precigenome LLC RNA-LNP (Lipid Nanoparticle) Formulation Product

Table 87. Precigenome LLC Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024) & (US$ Million)

Table 88. Precigenome LLC Recent Development

Table 89. Catalent Company Details

Table 90. Catalent Business Overview

Table 91. Catalent RNA-LNP (Lipid Nanoparticle) Formulation Product

Table 92. Catalent Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024) & (US$ Million)

Table 93. Catalent Recent Development

Table 94. Curapath Company Details

Table 95. Curapath Business Overview

Table 96. Curapath RNA-LNP (Lipid Nanoparticle) Formulation Product

Table 97. Curapath Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024) & (US$ Million)

Table 98. Curapath Recent Development

Table 99. Recipharm AB Company Details

Table 100. Recipharm AB Business Overview

Table 101. Recipharm AB RNA-LNP (Lipid Nanoparticle) Formulation Product

Table 102. Recipharm AB Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024) & (US$ Million)

Table 103. Recipharm AB Recent Development

Table 104. RiboPro Company Details

Table 105. RiboPro Business Overview

Table 106. RiboPro RNA-LNP (Lipid Nanoparticle) Formulation Product

Table 107. RiboPro Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024) & (US$ Million)

Table 108. RiboPro Recent Development

Table 109. VectorBuilder Inc. Company Details

Table 110. VectorBuilder Inc. Business Overview

Table 111. VectorBuilder Inc. RNA-LNP (Lipid Nanoparticle) Formulation Product

Table 112. VectorBuilder Inc. Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024) & (US$ Million)

Table 113. VectorBuilder Inc. Recent Development

Table 114. CordenPharma Company Details

Table 115. CordenPharma Business Overview

Table 116. CordenPharma RNA-LNP (Lipid Nanoparticle) Formulation Product

Table 117. CordenPharma Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024) & (US$ Million)

Table 118. CordenPharma Recent Development

Table 119. Thermo Fisher Scientific Company Details

Table 120. Thermo Fisher Scientific Business Overview

Table 121. Thermo Fisher Scientific RNA-LNP (Lipid Nanoparticle) Formulation Product

Table 122. Thermo Fisher Scientific Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024) & (US$ Million)

Table 123. Thermo Fisher Scientific Recent Development

Table 124. ProMab Company Details

Table 125. ProMab Business Overview

Table 126. ProMab RNA-LNP (Lipid Nanoparticle) Formulation Product

Table 127. ProMab Revenue in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024) & (US$ Million)

Table 128. ProMab Recent Development

Table 129. Research Programs/Design for This Report

Table 130. Key Data Information from Secondary Sources

Table 131. Key Data Information from Primary Sources

List of Figures

Figure 1. Global RNA-LNP (Lipid Nanoparticle) Formulation Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Type: 2023 VS 2030

Figure 3. Circular RNA-LNP Formulation Features

Figure 4. mRNA-LNP Formulation Features

Figure 5. Other Features

Figure 6. Global RNA-LNP (Lipid Nanoparticle) Formulation Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Application: 2023 VS 2030

Figure 8. Drug Delivery Case Studies

Figure 9. Vaccine Development Case Studies

Figure 10. Other Case Studies

Figure 11. RNA-LNP (Lipid Nanoparticle) Formulation Report Years Considered

Figure 12. Global RNA-LNP (Lipid Nanoparticle) Formulation Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global RNA-LNP (Lipid Nanoparticle) Formulation Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Region: 2023 VS 2030

Figure 15. Global RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Players in 2023

Figure 16. Global Top RNA-LNP (Lipid Nanoparticle) Formulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA-LNP (Lipid Nanoparticle) Formulation as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by RNA-LNP (Lipid Nanoparticle) Formulation Revenue in 2023

Figure 18. North America RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Type (2019-2030)

Figure 20. North America RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Application (2019-2030)

Figure 21. North America RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Country (2019-2030)

Figure 22. United States RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Type (2019-2030)

Figure 26. Europe RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Application (2019-2030)

Figure 27. Europe RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Country (2019-2030)

Figure 28. Germany RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. China RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Type (2019-2030)

Figure 36. China RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Application (2019-2030)

Figure 37. Asia RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Asia RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Type (2019-2030)

Figure 39. Asia RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Application (2019-2030)

Figure 40. Asia RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Region (2019-2030)

Figure 41. Japan RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. South Korea RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. China Taiwan RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Southeast Asia RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. India RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Australia RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Type (2019-2030)

Figure 49. Middle East, Africa, and Latin America RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Application (2019-2030)

Figure 50. Middle East, Africa, and Latin America RNA-LNP (Lipid Nanoparticle) Formulation Market Share by Country (2019-2030)

Figure 51. Brazil RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Mexico RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Turkey RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Israel RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. GCC Countries RNA-LNP (Lipid Nanoparticle) Formulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. WuXi XDC Revenue Growth Rate in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)

Figure 58. GenScript Revenue Growth Rate in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)

Figure 59. Creative Biogene Revenue Growth Rate in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)

Figure 60. Creative Biolabs Revenue Growth Rate in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)

Figure 61. Precigenome LLC Revenue Growth Rate in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)

Figure 62. Catalent Revenue Growth Rate in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)

Figure 63. Curapath Revenue Growth Rate in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)

Figure 64. Recipharm AB Revenue Growth Rate in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)

Figure 65. RiboPro Revenue Growth Rate in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)

Figure 66. VectorBuilder Inc. Revenue Growth Rate in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)

Figure 67. CordenPharma Revenue Growth Rate in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)

Figure 68. Thermo Fisher Scientific Revenue Growth Rate in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)

Figure 69. ProMab Revenue Growth Rate in RNA-LNP (Lipid Nanoparticle) Formulation Business (2019-2024)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed